© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
February 04, 2011
The antihyperglycemic therapeutic class will continue to be a major contributor to prescription drug trends in 2011 and beyond.
December 22, 2010
Specialty drugs are a significant cost trend driver for the majority of plan sponsors.
October 28, 2010
Increased generic substitution is projected to erode prices and outpace
class utilization growth for proton pump inhibitors in 2010.
August 21, 2010
The dispensing rate for generic statins is expected to rise slowly due to increased volumes of simvastatin and pravastatin sodium moderated
by increased Crestor volumes.
July 16, 2010
Increases in the number of cancer cases being diagnosed and treated likely will drive cost trends for antineoplastic enzyme inhibitors.
April 28, 2010
Future costs of MS therapy are likely to increase due to new add-on therapy combined with double-digit growth in utilization for existing drugs.